BHLHE40 Knockout HEK293T Cell Line
Cat.No.:
EDC07836
Species:
Human
Cell Name:
HEK293T
Gene:
BHLHE40
Gene ID:
8553
Size:
1×10⁶cells
BHLHE40 Knockout HEK293T Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07836 |
|---|---|
| Product Name | BHLHE40 Knockout HEK293T Cell Line |
| Species | Human |
| Cell Line | HEK293T |
| Cellosaurus ID | CVCL_0063 |
| Cell Line Synonyms | Hek293T, HEK-293T, HEK 293T, HEK-293-T, HEK 293 T, 293-T, 293 T, 293T, Human Embryonic Kidney 293T, 293tsA1609neo |
| Gene ID | |
| Gene | BHLHE40 |
| Summary |
This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with ARNTL or compete for E-box binding sites in the promoter of PER1 and repress CLOCK/ARNTL's transactivation of PER1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. [provided by RefSeq, Feb 2014]
|
| Associated Diseases | Non-tumor |
| Digestion Time | 30 sec~1 min |
| Morphology | Adherent |
| Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS+1% NEAA+1% GlutaMax |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293T | STR Info (Cell bank) Cell Line: HEK293T | ||||
| Allele1 | Allele2 | Allele3 | Allele1 | Allele2 | Allele3 | |
| Amelogenin | X | X | ||||
| CSF1PO | 11 | 12 | 11 | 12 | ||
| D2S1338 | 19 | 19 | ||||
| D3S1358 | 15 | 16 | 17 | 15 | 16 | 17 |
| D5S818 | 8 | 9 | 8 | 9 | ||
| D7S820 | 11 | 11 | ||||
| D8S1179 | 11 | 12 | 14 | 12 | 14 | |
| D13S317 | 12 | 14 | 12 | 14 | ||
| D16S539 | 9 | 13 | 9 | 13 | ||
| D18S51 | 17 | 18 | 17 | 18 | ||
| D19S433 | 18 | 18 | ||||
| D21S11 | 28 | 30.2 | 28 | 30.2 | ||
| FGA | 23 | 23 | ||||
| Penta D | 9 | 10 | 9 | 10 | ||
| Penta E | 7 | 15 | 7 | 15 | ||
| TH01 | 7 | 9.3 | 7 | 9.3 | ||
| TPOX | 11 | 11 | ||||
| vWA | 16 | 19 | 16 | 19 | ||
| D6S1043 | 11 | |||||
| D12S391 | 19 | 21 | 19 | 21 | ||
| D2S441 | 11 | 15 | 11 | 15 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying BHLHE40 function, BHLHE40 Knockout HEK293T Cell Line or BHLHE40 overexpression HEK293T Cell Line?
The choice depends on whether you are studying BHLHE40 (DEC1, Stra13, SHARP2)'s role as a bHLH transcription factor or modeling its functions in circadian rhythm and emerging immune cell biology. The Knockout line is the standard tool for asking whether BHLHE40 is required for these processes — BHLHE40 is a basic helix-loop-helix transcription factor with characterized roles as a circadian rhythm repressor (binding E-box elements and competing with BMAL1-CLOCK), an immediate-early gene induced by serum/stress, and an emerging regulator of T cell biology (Treg/Th cell function) and macrophage polarization. Overexpression is useful for studying BHLHE40 gain-of-function effects.
For BHLHE40 research, the EDITGENE BHLHE40 Knockout in HEK293T is a workhorse mechanistic platform — HEK293T's very high transfection efficiency supports systematic structure-function studies. Rescue with wild-type or DNA-binding-deficient BHLHE40 enables structure-function studies. The knockout is valuable for studying circadian rhythm regulation, immediate-early transcription factor biology, and emerging BHLHE40 functions in immune cell biology (Treg homeostasis, anti-tumor T cell function — BHLHE40 has emerged as an interesting target in cancer immunotherapy research).
What are the application scenarios for this model?
Primary applications:
• Circadian rhythm regulation: PER1/PER2 expression and circadian gene programs in BHLHE40-null cells.
• E-box transcriptional repression: BHLHE40 target gene expression analysis given competitive E-box binding with BMAL1-CLOCK.
• Immune cell biology: in heterologous Treg/Th cell-relevant contexts, BHLHE40's emerging immunotherapy applications.
• Stress response: serum/hypoxia-induced BHLHE40 induction analysis.
EDITGENE recommends this HEK293T-based model for researchers investigating circadian transcriptional regulation and emerging BHLHE40 immune biology.
Is this BHLHE40 Knockout HEK293T Cell Line compatible with overexpression rescue experiments?
Yes. BHLHE40 rescue experiments require attention to bHLH transcription factor architecture:
• Construct design: use a codon-modified BHLHE40 sequence with a small C-terminal tag (FLAG, HA). BHLHE40 has N-terminal bHLH (basic helix-loop-helix) DNA-binding domain and C-terminal Orange domain (transcriptional repression) — preserve all elements.
• DNA-binding-deficient rescue: basic region mutations abolish E-box (CANNTG) binding.
• Repression-deficient rescue: Orange domain mutations disrupt corepressor interactions.
• Functional readout: rescue should restore E-box-mediated transcriptional repression of BHLHE40 target genes.
HEK293T transduces with very high efficiency and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download